Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications assessment therapy changes drug discontinuation among crohns disease patients using
… at Maui Derm Hawaii 2023. Assessing humanistic burden among patients with moderate to severe psoriasis in the United …
… 2 and 3 clinical trials for the treatment of numerous rare disease indications (chronic inflammatory demyelinating … (BP), idiopathic inflammatory myositis (IIM), thyroid eye disease (TED), dermatomyositis, and scleroderma). As they … conducted targeted literature reviews of the epidemiology, disease state, quality-of-life measures, and gaps in …
… Effective treatments can benefit caregivers as well as patients. However, inclusion of caregiver benefits into … be included in the economic evaluation, where relevant, among the 58 appraisals completed in 2018, only 3 included …
… picture of how well childhood immunizations prevent disease and the economic impact of this disease prevention. These new studies were conducted because of changes in disease epidemiology, vaccine uptake, and evolving …
… of treatments to helping reduce risks to patients to ensuring that patient preference is considered in … risks, value and potential of therapies available to patients worldwide. …
… and improve shared healthcare decision making. From patients and caregivers to busy medical professionals and … as a source of trustworthy information about a disease and its treatment. The potential benefits of … PLS to achieve meaningful patient involvement in drug or device development, registration, and reimbursement. …
… Rebecca Crawford Patient-Centered Outcomes Assessment Respiratory Gastroenterology Manchester, United … social media reviews to gain insights into patient disease experiences in a range of therapeutic areas including … and timelines. Ms. Crawford's work has led to articles in publications such as Journal of Medical Economics, Health and …
… health. Recent projects have included: Database analyses using claims and EMR data Decision-analytic models (cost …
… will be presented at AMCP 2022. Immunoglobulin initiation among patients with primary immunodeficiency diseases: a …
… Market Access and Outcomes Strategy Transcript Orphan drug reimbursement continues to pose significant challenges … Benefits Agency (TLV) has been influenced by disease severity and uncertainty in documentation but not by … TLV from 2017 through 2022. We examined data on TLV ICERs, disease severity, uncertainty in health economic analysis, …